Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Hikaru Fujioka"'
Autor:
Hirotaka Tokai, Yasuhiro Nagata, Ken Taniguchi, Naomi Matsumura, Amane Kitasato, Takayuki Tokunaga, Hiroaki Takeshita, Tamotsu Kuroki, Shigeto Maeda, Masahiro Ito, Hikaru Fujioka
Publikováno v:
Surgical Case Reports, Vol 3, Iss 1, Pp 1-7 (2017)
Abstract Background Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is extremely rare, and its biological behavior, pathogenesis, optimum treatments, and prognosis remain to be elucidated. We herein report a case of PRMC with an 80-month f
Externí odkaz:
https://doaj.org/article/9bea08d370f148fcac43ea3c748a0638
Autor:
Tarik A. Ahmad M.D., Susumu Eguchi, Katsuhiko Yanaga, Shungo Miyamoto, Yukio Kamohara, Hikaru Fujioka, Junichiro Furui, Takashi Kanematsu
Publikováno v:
Cell Transplantation, Vol 11 (2002)
We studied the effect of preoperative hepatocyte transplantation on the prevention of liver failure in cirrhotic rats after hepatic resection. Two groups of Lewis rats were rendered cirrhotic by IP injection of 1% dimethylnitrosamine and were subject
Externí odkaz:
https://doaj.org/article/5da2e65e132f4b8984d36738a9b270ca
Autor:
Yasushi Kawazoe, Susumu Eguchi, Nozomu Sugiyama, Hiroyuki Yuzawa, Yujo Kawashita, Hikaru Fujioka, Takashi Kanematsu M.D., F.A.C.S.
Publikováno v:
Cell Transplantation, Vol 8 (1999)
Nafamostat mesilate (NM), a protease inhibitor, possesses a cytoprotective effect and inhibits the activation of complement. The present study investigated whether NM has any protective effect against injury of porcine hepatocytes by human plasma in
Externí odkaz:
https://doaj.org/article/23326492a0264ad58d7fae14e8ceb808
Autor:
Hikaru Fujioka, Peter J. Hunt, Jacek Rozga, Guo-Du Wu, Donald V. Cramer, Achilles A. Demetriou, Albert D. Moscioni
Publikováno v:
Cell Transplantation, Vol 3 (1994)
Renewed interest in the transplantation of isolated hepatocytes into the liver as a potential therapy for liver disease has stimulated the development of methods for the identification of donor cells within the recipient organ. We describe a method f
Externí odkaz:
https://doaj.org/article/89bfca4046fd46089e90d49b2a367a4e
Autor:
Masayuki Ohta, Hikaru Fujioka, Masayuki Shiraishi, Hideo Baba, Tomoharu Yoshizumi, Shinichi Aishima, Yo-ichi Yamashita, Susumu Eguchi, Tatsunori Miyata
Publikováno v:
Cancer Science
Intrahepatic cholangiocarcinoma is a rare malignant biliary neoplasm that causes a poor prognosis even after curative hepatectomy. Liver metastasis is the major recurrence pattern of intrahepatic cholangiocarcinoma; therefore, the prevention of liver
Autor:
Hikaru Fujioka, Sayaka Kuba, Takashi Azuma, Shinichiro Ito, Tomoo Kitajima, Mitsutoshi Matsuo, Susumu Eguchi, Kazuya Okada, Ryuichiro Suto, Yuka Mine, Masashi Haraguchi, Hiroki Moriuchi, Mitsuhisa Takatsuki, Kengo Kanetaka, Izumi Yamaguchi, Yukio Kamohara, Koji Natsuda, Takahiro Enjoji, Yusuke Inoue, Taiichiro Kosaka, Tomohiko Adachi, Satomi Okada, Ayaka Ikebe, Tamotsu Kuroki, Chika Sakimura, Kosho Yamanouchi, Shinichiro Ono, Hanako Tetsuo, Masaaki Hidaka, Naomi Hayashida, Ken Taniguchi, Shun Yamaguchi, Yasuhiro Torashima, Michi Morita, Kazuma Kobayashi, Syunsuke Kawakami, Akihito Enjoji, S. Fukui, Akihiko Soyama, Toshiaki Hashimoto
Publikováno v:
The Kurume medical journal. 66(1)
This multicenter phase II N-DOCC-F-C-1701 trial is being planned in order to investigate the efficacy and safety of CPT-11+S-1 +Ramucirumab (IRIS+Rmab), which is anticipated to have a stronger anti-tumor effect than IRIS+Bmab in patients with metasta
Publikováno v:
Journal of Japan Society of Civil Engineers, Ser. A1 (Structural Engineering & Earthquake Engineering (SE/EE)). 78:I_494-I_502
Autor:
Toru Beppu, Koji Okuda, Masayuki Ohta, Kazuhiro Kondo, Yuko Takami, Kenji Kitahara, Atsushi Nanashima, Shinichi Ueno, Susumu Eguchi, Tomoaki Noritomi, Masaaki Hidaka, Ken Shirabe, Hikaru Fujioka, Masayuki Shiraishi
Publikováno v:
Annals of Surgery. 271(2):339-346
Objective: The aim of the present study was to evaluate the value of anatomical resection for HCC with micro-portal vascular invasion (vp1) between 2000 and 2010. Summary of Background: Vascular invasion has been reported as a prognostic factor of li
Autor:
Hikaru Fujioka, Tamotsu Kuroki
Publikováno v:
Surgery Today. 49:103-107
In recent years, laparoscopic procedures have developed rapidly, and the reports of laparoscopic pancreatic resection including laparoscopic pancreaticoduodenectomy (LPD) have increased in number. Although LPD is a complex procedure with high mortali
Autor:
Hiroaki Takeshita, Hikaru Fujioka, Shigeto Maeda, Takayuki Tokunaga, Tamotsu Kuroki, Ken Taniguchi, Amane Kitasato
Publikováno v:
Surgery Today. 48:804-809
Laparoscopic splenectomy (LS) has become the standard operative approach for splenectomy. Portal or splenic vein thrombosis (PSVT) is a serious and common complication after LS, and lethal complications of PSVT can occur when the portal vein is compl